PPS Study- Screening and Classification of Pentosan-Associated Maculopathy in Patients with Interstitial Cystitis
Recruiting
18 years - 99 years
All
Phase
N/A
600 participants needed
1 Location
Brief description of study
The primary objective of this study is to determine the prevalence of retinal changes in patients using pentosan polysulfate sodium (PPS) for treatment of interstitial cystitis and further characterize this condition using multimodal imaging. Additionally, this study aims to identify additional clinical findings associated with PPS maculopathy and to gain insight into the pathophysiology of PPS maculopathy based on findings from multimodal imaging.
The primary endpoint of the study will be to identify the prevalence of PPS-associated maculopathy in patients receiving PPS for interstitial cystitis. The secondary endpoint will be to identify potential factors (e.g. cumulative dose exposure) associated with elevated risk of developing PPS-associated maculopathy.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: interstitial cystitis,retina
-
Age: 18 years - 99 years
-
Gender: All
- History of interstitial cystitis
- Currently or previously prescribed pentosan polysulfate sodium
- Exclusion includes: Significant media opacities which may interfere with fundus imaging.
Updated on
04 Aug 2024.
Study ID: 848624
Find a site
,
Your Information has been sent successfully.
Send a message
Enter your contact details to connect with study team
Primary Contact
